MRE plus FIB-4 bests MAST, FAST to ‘rule in or rule out’ stage 2 fibrosis in NAFLD
LONDON — Magnetic resonance elastography in combination with the fibrosis-4 index was a better predictor of significant fibrosis in patients with nonalcoholic fatty liver disease vs. other noninvasive techniques, noted a presenter here.“NALFD patients with significant fibrosis — defined as those who have stage 2 or higher — are candidates for pharmacological treatments,” Rohit Loomba, MD, MHSc, director of hepatology and the NAFLD Research Center at UC San Diego School of Medicine, told attendees at the International Liver Congress. “Considering high screenRead More